Skip to content

Lineage Cell Therapeutics, Inc.: filings

Every Lineage Cell Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 2026461290001193125-26-338064
10-Q2026-05-12fiscal Q1 202646960001193125-26-219479
10-K2026-03-05fiscal FY 2025511050001193125-26-093992
10-Q2025-11-06fiscal Q3 2025471300001193125-25-269599
10-Q2025-08-12fiscal Q2 2025471300000950170-25-107333
10-Q2025-05-13fiscal Q1 2025481010000950170-25-070378
10-K2025-03-10fiscal FY 2024511040000950170-25-036309
10-Q2024-11-14fiscal Q3 2024501460000950170-24-127077
10-Q2024-08-08fiscal Q2 2024501430000950170-24-094004
10-Q2024-05-09fiscal Q1 2024511070000950170-24-056998
10-K2024-03-07fiscal FY 2023541580000950170-24-027988
10-Q2023-11-09fiscal Q3 2023521490001493152-23-040058
10-Q2023-08-10fiscal Q2 2023511420001493152-23-027552
10-Q2023-05-11fiscal Q1 202350970001493152-23-016392
10-K2023-03-09fiscal FY 2022501380001493152-23-007129
10-Q2022-11-10fiscal Q3 2022511470001493152-22-031359
10-Q2022-08-11fiscal Q2 2022491390001493152-22-022085
10-Q2022-05-12fiscal Q1 202246920001493152-22-013041
10-K2022-03-10fiscal FY 2021491330001493152-22-006520
10-Q2021-11-10fiscal Q3 2021471410001493152-21-027859
10-Q2021-08-12fiscal Q2 2021461340001493152-21-019518
10-Q2021-05-13fiscal Q1 202144910001493152-21-011299
10-K2021-03-11fiscal FY 2020481260001493152-21-005814
10-Q2020-11-04fiscal Q3 2020471410001641172-20-000034
10-Q2020-08-06fiscal Q2 2020461330001493152-20-014858
10-Q2020-05-07fiscal Q1 202044910001493152-20-007956
10-K2020-03-12fiscal FY 2019491210001493152-20-003818
10-Q2019-11-12fiscal Q3 2019461360001493152-19-016930
10-Q2019-08-08fiscal Q2 2019461330001493152-19-011906
10-Q2019-05-09fiscal Q1 201946920001493152-19-006673
10-K2019-03-14fiscal FY 2018431160001493152-19-003335
10-Q2018-11-08fiscal Q3 2018441310001493152-18-015428
10-Q2018-08-02fiscal Q2 2018441310001493152-18-010859
10-Q2018-05-10fiscal Q1 201843880001493152-18-006559
10-K2018-03-15fiscal FY 2017451520001493152-18-003416
10-Q2017-11-09fiscal Q3 2017431220001140361-17-041841
10-Q2017-08-09fiscal Q2 2017421200001140361-17-030912
10-Q2017-05-10fiscal Q1 201739800001140361-17-019338
10-K2017-03-16fiscal FY 2016431390001140361-17-012402
10-Q2016-11-04fiscal Q3 2016381140001140361-16-084920
10-Q2016-08-09fiscal Q2 2016381140001140361-16-075508
10-Q2016-05-10fiscal Q1 201635720001140361-16-064329
10-K2016-03-15fiscal FY 2015401300001140361-16-057879
10-Q2015-11-09fiscal Q3 2015411120001140361-15-040074
10-Q2015-08-10fiscal Q2 2015411100001140361-15-030782
10-Q2015-05-08fiscal Q1 201542860001140361-15-018544
10-K2015-03-11fiscal FY 2014441370001140361-15-011259
10-Q2014-11-07fiscal Q3 2014411090001140361-14-040755
10-Q2014-08-11fiscal Q2 2014411080001140361-14-031789
10-Q2014-05-12fiscal Q1 201443880001140361-14-020012
10-K2014-03-17fiscal FY 2013431370001140361-14-013083
10-Q2013-11-12fiscal Q3 201339980001140361-13-041885
10-Q2013-08-09fiscal Q2 2013391000001140361-13-031473
10-Q2013-05-10fiscal Q1 201339800001140361-13-020144
10-K2013-03-18fiscal FY 2012411300001140361-13-012991
10-Q2012-11-09fiscal Q3 201238980001140361-12-046522
10-Q2012-08-09fiscal Q2 201238980001140361-12-036083
10-Q2012-05-10fiscal Q1 201231640001140361-12-024475
10-K2012-03-14fiscal FY 201132850001140361-12-015539
10-Q2011-11-08fiscal Q3 201132800001140361-11-052355
10-Q2011-08-09fiscal Q2 201132800001140361-11-040659

Inspect the source

Entity
Lineage Cell Therapeutics, Inc. / CIK 0000876343
Captured
2026-09-20T05:01:04.503Z
SEC response SHA-256
de850ac42665e48058d541d948514740e0c9007b61646401dcae831c504c80bf

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000876343.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))